Abstract
Objective: Vitamin D deficiency is associated with increased risks of arterial and venous cardiovascular events. Hypothetically, supplementation with vitamin D may lead to a less prothrombotic phenotype, as measured by global coagulation assays and fibrin clot structure. Methods: In this prospective cohort study, we enrolled adult outpatients attending the Primary Care division of the Geneva University Hospitals with a severe vitamin D deficiency (25-hydroxyvitamin-D3 (25-OHD) <25nmol/L), excluding obese patients or with a recent acute medical event. We evaluated changes in coagulation times, thrombin generation assay, clot formation and clot lysis time, 25-OHD and parathormone before and 1-3 months after cholecalciferol oral supplementation with one-time 300,000UI then 800UI daily. Paired t-tests with a two-sided alpha of 0.05 compared absolute mean differences. Results: The 48 participants had a mean age of 43.8±13.8 years. After supplementation, 25-OHD levels increased from 17.9±4.6 nmol/L to 62.5±20.7 nmol/L 6.4±3.0 weeks after inclusion. Endogenous thrombin potential and thrombin generation peak values both decreased significantly (-95.4nM*min (95%CI -127.9 to -62.8), P<0.001; -15.1nM (-23.3 to -6.8), P<0.001). The maximum absorbance by turbidimetry decreased significantly (P=0.001) after supplementation. There was no change in clot lysis time, coagulation times or plasminogen activator inhibitor-1 and homocysteine levels. Conclusions: In severe vitamin D deficiency, a high-dose cholecalciferol supplementation was associated with a reduction in thrombin generation and an average decreased number of fibrin protofibrils per fibers and fibrin fiber size measured by turbidimetry. This suggests that severe vitamin D deficiency may be associated with a potentially reversible prothrombotic profile.

This publication has 24 references indexed in Scilit: